what is glp 1 hormone GLP-1 GLP-1 Genetics: How Genes Affect

investigated the synergistic effects of MSTN inhibitors and GLP-1 agonists by administering apitegromab in combination with semaglutide, a GLP-1 agonist, and tirzepatide, a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide, in patients with obesity (NCT06445075)

The Precision Peptide Genetic Test reveals genetic variants associated with GLP-1 receptor function and appetite regulation, which should be interpreted with your healthcare provider as part of a comprehensive, personalized medical assessment

Meisha K

Read the original article on EatingWell

Neither experience is a sign of success or failure

Study-related adverse events Adverse reactions reported in 5% of patients and occurring more frequently with Victoza compared with placebo included nausea (21.4% vs 4.4%), vomiting (12.1% vs 2.2%), diarrhea (7.1% vs 2.9%), constipation (5.7% vs 1.5%), increased lipase (15.0% vs 8.8%), GFR decreased (6.4% vs 5.1%), and headache (5.0% vs 2.9%)